Adjuvant radiotherapy in locally confined prostate cancer

Anticancer Research

Volumn 23, Issue 2 A, 2003, Pages 983-985

  Schäfer, Ulrich ^a   Witt, Frank ^a   Micke, Oliver ^a   Willich, Normann ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Clinical study; Prostate cancer; PSA; Radiation therapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ANTIGEN DETECTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONFERENCE PAPER; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN TISSUE; MALE; PELVIS LYMPH NODE; PELVIS LYMPHADENECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATECTOMY; RADIATION DOSE; RISK FACTOR; SAMPLING; SURVIVAL TIME;

COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; HUMANS; MALE; MONITORING, PHYSIOLOGIC; PHOTONS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RECURRENCE; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 0038538305     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (9)

1. Silverberb E, Boring CC and Squires TS: Cancer statistics, 1990. CA 40: 9-26, 1990.
2. Ray GR, Bagshaw MA and Freiha F: External beam radiation salvage for residual or recurrent local tumor following radical prostatectomy. J Urol 132: 926, 1984.
3. Paulson DF, Moul JW, Robertson JE and Walther PJ: Postoperative radiotherapy of the prostate for patients undergoing radical prostatectomy with positive margins, seminal vesicle involvement and/or penetration through the capsule [see comments]. J Urol 143: 1178-1182, 1990.
4. Asbell SO, Martz KL, Shin KH, Sause WT, Doggett RL, Perez CA and Pilepich MV: Impact of surgical staging in evaluating the radiotherapeutic outcome in RTOG #77-06, a phase III study for T1 BNOMO (A2) and T2NOMO (B) prostate carcinoma. Int J Radiat Oncol Biol Phys 40: 769-782, 1998.
5. Wirth M, Manseck A and Helke C: What should be done in positive margins after radical prostatectomy Urologe A 37: 135-7, 1998.
6. Valicenti RK, Gomella LG, Ismail M, Strup SE, Mulholland SG, Dicker AP, Petersen RO and Newschaffer CJ: The efficacy of early adjuvant radiation therapy for pT3NO prostate cancer: a matched-pair analysis. Int J Radiat Oncol Biol Phys 45: 53-8, 1999.
7. Buskirk SJ, Schild SE, Durr ED, Robinow JS, Bock FF, Wolfe JT, Tomera KM and Ferrigni RG: Evaluation of serum prostate-specific antigen levels after postoperative radiation therapy for pathologic stage T3, NO prostate cancer. Mayo Clin Proc 71: 242-8, 1996.
8. Valicenti RK, Gomella LG, Ismail M, Mulholland SG, Petersen RO and Corn BW: Effect of higher radiation dose on biochemical control after radical prostatectomy for PT3NO prostate cancer. Int J Radiat Oncol Biol Phys 42: 501-6, 1998.
9. Vicini FA, Ziaja EL, Kestin LL, Brabbins DS, Stromberg JS, Gonzalez JA and Martinez AA: Treatment outcome with adjuvant and salvage irradiation after radical prostatectomy for prostate cancer. Urology 54: 111-117, 1999.